A A
- Acromegaly - pasireotide - initial authority application form (PB181)
- Acromegaly - pegvisomant - initial authority application form (PB225)
- Acute lymphoblastic leukaemia - blinatumomab - initial (induction) authority application form (PB210)
- Acute lymphoblastic leukaemia - inotuzumab ozogamicin - initial (induction) authority application form (PB269)
- Acute lymphoblastic leukaemia - ponatinib - initial authority application form (PB169)
- Acute lymphoblastic leukaemia first line - dasatinib - initial (induction and consolidation) authority application form (PB271)
- Acute lymphoblastic leukaemia second line - dasatinib - initial authority application form (PB077)
- Acute myeloid leukaemia - midostaurin - initial maintenance authority application form (PB253)
- Acute myeloid leukaemia - oral azacitidine - dose escalation therapy continuing authority application form (PB355)
- Adult Crohn’s Disease Activity Index form (PB393)
- Aged care application for the dementia and cognition supplement in home care provided before 1 November 2025 form (AC014)
- Aged care entry record form (AC021)
- Aged Care Funding Instrument - Application for classification form (AC001)
- Aged Care Provider Portal - register, amend or remove users form (AC004)
- Ankylosing spondylitis - change or recommencement authority application form (PB251)
- Ankylosing spondylitis - continuing authority application form (PB074)
- Ankylosing spondylitis - initial authority application form (PB073)
- Application for a Medicare provider number and/or prescriber number for a medical practitioner form (HW019)
- Application for a Medicare provider number and/or prescriber number for a nurse practitioner or midwife form (HW088)
- Application for a Medicare provider number or prescriber number for allied health, other primary health care, and non-medical health professionals form (HW093)
- Application for an authorised recipient to apply for or renew access to the Provider Directory System form (MO003)
- Application for approval, amendment or renewal of an approved pathology authority form (HW011)
- Application for approval, amendment or renewal of an approved pathology practitioner form (HW009)
- Application for approval, amendment or renewal of premises as an accredited pathology laboratory form (HW010)
- Application for approval, amendment, renewal or cancellation of an approved collection centre form (HW035)
- Application for bulk bill claim adjustment form (DB018)
- Application for Department of Veterans’ Affairs claim adjustment form (DB021)
- Application for late lodgement of a Simplified Billing claim for assigned Medicare benefits form (HW026)
- Application for recognition as a specialist or consultant physician form (HW077)
- Application for remote area exemption for R-type diagnostic imaging services for a medical practitioner form (HW065)
- Application for the oxygen and/or enteral feeding supplement form (AC011)
- Application to add or change approved care service's bank details form (AC015)
- Application to register or amend a diagnostic imaging or radiation oncology practice form (HW061)
- Approved Pathology Authority acquisition or merger advice form (HW036)
- Approved supplier manual payment reconciliation form (PB242)
- Assignment of benefit Medicare bulk bill Webclaim form (DB020)
- Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - continuing authority application form (PB125)
- Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - initial or switching authority application form (PB119)
- Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - recommencement authority application form (PB176)
- Atypical haemolytic uraemic syndrome (aHUS) - ravulizumab - initial grandfather authority application form (PB359)
- Australian Immunisation Register (AIR) - application to register as a vaccination provider form (IM004)
- Australian Immunisation Register (AIR) - bank account details for vaccination providers form (IM005)
- Australian Immunisation Register (AIR) - ceasing correspondence and release of information form (IM017)
- Australian Immunisation Register (AIR) - immunisation encounter form (IM018)
- Australian Immunisation Register (AIR) - immunisation history form (IM013)
- Australian Immunisation Register immunisation medical contraindication or natural immunity form (IM011)
B B
C C
- CD30 positive systemic anaplastic large cell lymphoma - brentuximab vedotin - initial authority application form (PB123)
- Centrelink Medical Certificate form (SU415)
- Chronic myeloid leukaemia - asciminib or ponatinib - continuing authority application form (PB084)
- Chronic myeloid leukaemia - asciminib or ponatinib - initial authority application form (PB171)
- Chronic myelomonocytic leukaemia - azacitidine - initial authority application form (PB079)
- Chronic myelomonocytic leukaemia - decitabine+cedazuridine - initial authority application form (PB340)
- Chronic pouchitis - vedolizumab - initial or recommencement authority application form (PB379)
- Chronic rhinosinusitis with nasal polyps - mepolizumab - initial authority application form (PB348)
- Chronic thromboembolic pulmonary hypertension - riociguat - initial authority application form (PB192)
- Chronic treatment of Acute Hepatic Porphyria - givosiran - continuing authority application form (PB400)
- Chronic treatment of Acute Hepatic Porphyria - givosiran - initial authority application form (PB399)
- Consent to release an aged care client record form (AC010)
- COVID-19 Vaccine Claims Scheme cost calculation form (MO065)
- Crohn's disease paediatric - change or recommencement authority application form (PB239)
- Crohn's disease paediatric - continuing authority application form (PB161)
- Crohn's disease paediatric - initial authority application form (PB085)
- Cutaneous T-cell lymphoma (CTCL) - brentuximab vedotin - initial authority application form (PB268)
- Cutaneous T-cell lymphoma - mogamulizumab or vorinostat - initial authority application form (PB216)
- Cystic fibrosis - elexacaftor+tezacaftor+ivacaftor or vanzacaftor+tezacaftor+deutivacaftor - continuing authority application form (PB287)
- Cystic fibrosis - elexacaftor+tezacaftor+ivacaftor or vanzacaftor+tezacaftor+deutivacaftor - initial authority application form (PB286)
- Cystic fibrosis - ivacaftor - continuing authority application form (PB126)
- Cystic fibrosis - ivacaftor - initial authority application form (PB120)
- Cystic fibrosis - lumacaftor+ivacaftor or tezacaftor+ivacaftor - continuing authority application form (PB244)
- Cystic fibrosis - lumacaftor+ivacaftor or tezacaftor+ivacaftor - initial authority application form (PB243)
D D
F F
- Fabry disease - migalastat - initial authority application form (PB373)
- Fabry disease - migalastat - initial grandfather authority application form (PB374)
- Fibrodysplasia ossificans progressiva - palovarotene - chronic treatment authority application form (PB387)
- Fistulising Crohn's disease - continuing authority application form (PB093)
- Fistulising Crohn's disease - initial or recommencement (treatment break greater than 5 years) authority application form (PB092)
- Fistulising Crohn’s disease - change or recommencement (treatment break less than 5 years) authority application form (PB236)
G G
- Gastrointestinal stromal tumour - sunitinib - initial authority application form (PB096)
- General (S85) Schedule - opioid treatment authority application form (PB294)
- General practitioner 90 day pay doctor cheque scheme application form (HW074)
- Generalised myasthenia gravis - acute severe treatment authority application form (PB394)
- Generalised myasthenia gravis - bridging therapy authority application form (PB395)
- Generalised myasthenia gravis - treatment refractory continuing authority application form (PB397)
- Generalised myasthenia gravis - treatment refractory initial authority application form (PB396)
- Generalised myasthenia gravis - treatment refractory initial grandfather authority application form (PB398)
- Giant cell arteritis - tocilizumab - initial authority application form (PB272)
- Growth hormone deficiency - childhood onset initial authority application form (PB288)
- Growth hormone deficiency - late onset initial authority application form (PB248)
- Growth hormone paediatric - change or recommencement authority application form (PB165)
- Growth hormone paediatric - continuing as a reclassified patient authority application form (PB164)
- Growth hormone paediatric - continuing authority application form (PB163)
- Growth hormone paediatric - initial authority application form (PB162)
- Growth hormone paediatric - recommencement as a reclassified patient authority application form (PB166)
- Growth hormone paediatric - somapacitan or somatrogon - initial grandfather authority application form form (PB339)
H H
- Healthcare Identifiers Service - Application to register a new entity form (HW013)
- Healthcare Identifiers Service application to deactivate or retire a contracted service provider organisation form (HW048)
- Hereditary angioedema Types 1 or 2 - garadacimab - initial grandfather authority application form (PB326)
- Hereditary angioedema Types 1 or 2 - garadacimab or lanadelumab - initial or change authority application form (PB325)
- Hereditary transthyretin amyloidosis - patisiran or vutrisiran - continuing authority application form (PB368)
- Hereditary transthyretin amyloidosis - patisiran or vutrisiran - initial authority application form (PB367)
- HI Service - application to add, replace or remove a contracted service provider officer form (HW046)
- HI Service - application to amend a contracted service provider officer's details form (HW047)
- HI Service - application to amend a healthcare provider record form (HW034)
- HI Service - application to amend an organisation officer's personal details form (HW042)
- HI Service - application to amend details of a contracted service provider organisation record form (HW043)
- HI Service - application to deactivate, reactivate or retire a healthcare organisation form (HW044)
- HI Service - application to register a healthcare support service provider form (HW096)
- HI Service - My Health Record system - application to register a contracted service provider organisation record form (HW012)
- High-risk neuroblastoma - eflornithine - initial authority application form (PB384)
I I
J J
- Juvenile idiopathic arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application form (PB323)
- Juvenile idiopathic arthritis - for adult patients with onset prior to age 18 - change or recommencement authority application form (PB282)
- Juvenile idiopathic arthritis - for adult patients with onset prior to age 18 - continuing authority application form (PB063)
- Juvenile idiopathic arthritis - for adult patients with onset prior to age 18 - initial authority application form (PB062)
M M
- Manual identity verification for Provider Digital Access form (HW080)
- Manual Prescription processing fee form (PB259)
- Medical indemnity request to aggregate payments for the same claim form (MO008)
- Medicare Easyclaim enquiry form (HW059)
- Medicare stationery order form (DB6Ba)
- Medicine export declaration form (PB302)
- Metastatic HER2 positive breast cancer - lapatinib - initial authority application form (PB099)
- Metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - continuing authority application form (PB207)
- Metastatic or locally advanced basal cell carcinoma - sonidegib or vismodegib - initial authority application form (PB206)
- Midwife Professional Indemnity Run-Off Cover Scheme - Application for payment form (MO068)
- Midwife Professional Indemnity Run-Off Cover Scheme - Midwife who has ceased practice because of maternity form (MO041)
- Midwife Professional Indemnity Scheme - Application for a Qualifying Claim Certificate form (MO067)
- Midwife Professional Indemnity Scheme - Application for payment form (MO069)
- Moderate to severe hidradenitis suppurativa - bimekizumab - initial grandfather authority application form (PB364)
- Moderate to severe hidradenitis suppurativa - continuing authority application form (PB219)
- Moderate to severe hidradenitis suppurativa - initial, change or recommencement authority application form (PB218)
- Multiple myeloma dual therapy - pomalidomide - initial authority application form (PB214)
- Multiple myeloma newly diagnosed dual therapy - lenalidomide - initial authority application form (PB200)
- Multiple myeloma newly diagnosed monotherapy - lenalidomide - initial authority application form (PB291)
- Multiple myeloma newly diagnosed triple therapy - lenalidomide - initial authority application form (PB293)
- Multiple myeloma progressive disease - lenalidomide - initial authority application form (PB158)
- Myelodysplastic syndrome - lenalidomide - initial or first continuing authority application form (PB012)
- MyMedicare Incentives Review of decision form (IP034)
N N
- Narcolepsy without cataplexy - armodafinil or modafinil - initial authority application form (PB104)
- Neurofibromatosis type 1 - selumetinib - initial authority application form (PB370)
- Neurofibromatosis type 1 - selumetinib - initial grandfather authority application form (PB371)
- Neuromyelitis optica spectrum disorder - ravulizumab - initial authority application form (PB382)
- Non-infectious uveitis - adalimumab - initial authority application form (PB372)
- Non-radiographic axial spondyloarthritis - initial authority application form (PB255)
- Non-small cell lung cancer - initial authority application form (PB156)
- Notification of Australian Business Number and reference identification for tax treatment purposes and recipient created tax invoice agreement form (HW055)
- Notification of bank account details for Aboriginal Health Services program payments form (PB019)
O O
P P
- Palliative Care Schedule - opioid treatment authority application form (PB306)
- Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - continuing authority application form (PB328)
- Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - initial grandfather authority application form (PB329)
- Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - initial, switching, returning or balance of supply authority application form (PB327)
- Paroxysmal nocturnal haemoglobinuria - iptacopan or pegcetacoplan - initial authority application form (PB343)
- Paroxysmal nocturnal haemoglobinuria - iptacopan or pegcetacoplan - initial grandfather authority application form (PB345)
- Paroxysmal nocturnal haemoglobinuria - iptacopan or pegcetacoplan continuing or returning authority application form (PB344)
- PASI calculation and body diagram - face, hand and foot form (PB114)
- PASI calculation and body diagram - whole body form (PB115)
- PBS Safety Net claim for payment form (PB241)
- Peripheral T-cell lymphoma (PTCL) - brentuximab vedotin - initial authority application form (PB314)
- Polycythemia vera - ruxolitinib - initial authority application form (PB388)
- Practice Incentives Additional practice branch form (IP025)
- Practice Incentives application form (IP001)
- Practice Incentives change of practice details form (IP005)
- Practice Incentives Change of practice ownership form (IP010)
- Practice Incentives individual general practitioner or nurse practitioner details form (IP003)
- Practice Incentives Practice closure or withdrawal form (IP007)
- Practice Incentives practice ownership details and declaration form (IP008)
- Practice Incentives Program After Hours Incentive application form (IP030)
- Practice Incentives Program Indigenous Health Incentive patient registration and consent form (IP017)
- Practice Incentives Program Indigenous Health Incentive patient withdrawal of consent form (IP029)
- Practice Incentives Program Indigenous Health Incentive practice application form (IP026)
- Practice Incentives Program Procedural General Practitioner Payment application form (IP004)
- Practice Incentives Program Teaching Payment claim form (IP006)
- Practice Incentives review of decision form (IP027)
- Primary hyperoxaluria type 1 - lumasiran - continuing authority application form (PB390)
- Primary hyperoxaluria type 1 - lumasiran - initial authority application form (PB389)
- Primary hyperoxaluria type 1 - lumasiran - initial grandfather authority application form (PB391)
- Private health insurer registrations and updates for ECLIPSE form (HW081)
- Progressive familial intrahepatic cholestasis - odevixibat - initial authority application form (PB392)
- Progressive fibrosing interstitial lung disease - nintedanib - initial authority application form (PB332)
- Provider registration for Electronic Funds Transfer payments form (HW029)
- Psoriatic arthritis - change or recommencement authority application form (PB260)
- Psoriatic arthritis - continuing authority application form (PB106)
- Psoriatic arthritis - initial authority application form (PB105)
- Pulmonary arterial hypertension - initial dual or triple therapy authority application form (PB303)
- Pulmonary arterial hypertension - initial monotherapy authority application form (PB070)
R R
- Register or update for aged care web services form (AC027)
- Remote Area Aboriginal Health Services request and claim form (PB042)
- Request for pay group link form (HW078)
- Request for Pharmaceutical Benefits Scheme claims information form (MS040)
- Request to revoke or reissue a NASH PKI certificate form (HW083)
- Resubmit rejected items for Remote Area Aboriginal Health Services claim form (PB354)
- Retinal vein occlusion - initial authority application form (PB154)
- Rheumatoid arthritis - change of treatment after resolution of critical shortage of tocilizumab authority application form (PB324)
- Rheumatoid arthritis - change or recommencement authority application form (PB247)
- Rheumatoid arthritis - continuing authority application form (PB111)
- Rheumatoid arthritis - initial authority application form (PB109)
- ROCS - midwife medical certificate for maternity form (MO043)
- ROCS - midwife medical certificate for permanent disability form (MO060)
- Run off Cover Indemnity Scheme - medical certificate maternity form (MO032)
- Run off Cover Indemnity Scheme - medical certificate permanent disability form (MO056)
S S
- Seemingly valid Medicare card form (PB136)
- Severe aplastic anaemia - eltrombopag - initial authority application form (PB362)
- Severe asthma - adolescent and adult - change authority application form (PB285)
- Severe asthma - adolescent and adult - continuing authority application form (PB076)
- Severe asthma - adolescent and adult - initial or recommencement after 12 months break authority application form (PB075)
- Severe asthma adolescent and adult - tezepelumab - initial grandfather authority application form (PB304)
- Severe asthma paediatric - change or continuing authority application form (PB385)
- Severe asthma paediatric - dupilumab - initial grandfather authority application form (PB386)
- Severe asthma paediatric - dupilumab or omalizumab - initial or recommencement authority application form (PB188)
- Severe chronic plaque psoriasis - change or recommencement authority application form (PB263)
- Severe chronic plaque psoriasis - continuing authority application form (PB113)
- Severe chronic plaque psoriasis - initial authority application form (PB112)
- Severe chronic plaque psoriasis paediatric - adalimumab or ustekinumab - continuing authority application form (PB319)
- Severe chronic plaque psoriasis paediatric - adalimumab or ustekinumab - initial, change or recommencement authority application form (PB320)
- Severe chronic spontaneous urticaria - omalizumab - initial authority application form (PB223)
- Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - continuing authority application form (PB337)
- Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - initial authority application form (PB336)
- Short bowel syndrome with intestinal failure - teduglutide - continuing authority application form (PB276)
- Short bowel syndrome with intestinal failure - teduglutide - initial authority application form (PB275)
- Simplified Billing manual claims batch header form (HW091)
- Simplified Billing or ECLIPSE adjustment claim form (HW023)
- Solid tumours with confirmed NTRK gene fusion - larotrectinib - initial authority application form (PB333)
- Spinal muscular atrophy - onasemnogene abeparvovec - authority application form (PB330)
- Spinal muscular atrophy adult - nusinersen or risdiplam - initial authority application form (PB334)
- Spinal muscular atrophy paediatric - nusinersen or risdiplam - initial authority application form (PB233)
- Statutory declaration - Midwife Professional Indemnity Scheme - Online claim form (MO042)
- Statutory declaration ROCS - Deceased medical practitioner form (MO033)
- Statutory declaration ROCS - Deceased midwife form (MO040)
- Statutory declaration ROCS - Medical practitioner who has ceased medical practice because of maternity form (MO037)
- Statutory declaration ROCS - Medical practitioner who has ceased medical practice because of permanent disability form (MO036)
- Statutory declaration ROCS - Medical practitioner who has ceased private or all remunerated medical practice due to retirement form (MO031)
- Statutory declaration ROCS - Medical practitioner who has not engaged in either private or remunerated medical practice during the preceding 3 years form (MO034)
- Statutory declaration ROCS - Midwife ceased practice because of permanent disability form (MO038)
- Statutory declaration ROCS - Midwife who has ceased practice form (MO039)
- Statutory declaration ROCS - Midwife who has not engaged in a private practice during the preceding 3 years form (MO044)
- Statutory declaration ROCS - Overseas medical practitioner form (MO035)
- Subfoveal choroidal neovascularisation - initial authority application form (PB072)
- Symptomatic obstructive hypertrophic cardiomyopathy - mavacamten - initial authority application form (PB360)
- Systemic light chain amyloidosis newly diagnosed - daratumumab - initial authority application form (PB341)
- Systemic lupus erythematosus - anifrolumab - initial authority application form (PB365)
U U
- Ulcerative colitis adult - change or recommencement authority application form (PB245)
- Ulcerative colitis adult - initial authority application form (PB127)
- Ulcerative colitis paediatric - change or recommencement authority application form (PB246)
- Ulcerative colitis paediatric - initial authority application form (PB215)